35th week of 2021 patent applcation highlights part 9 |
Patent application number | Title | Published |
20210267912 | METHYL SULFONYL METHANE-CONTAINING COMPOSITION FOR PREVENTING OR ALLEVIATING OBESITY, FATTY LIVER, AND DIABETES | 2021-09-02 |
20210267913 | EDIBLE, SINGLE-EXTRACTION CURCUMA EXTRACTS | 2021-09-02 |
20210267914 | A Composition for Treatment, Prevention, or Amelioration of Alzheimer's Disease, a Composition for Suppression of Brain Nerve Cell Death, a Composition for Suppression of Microglia Activation Induced by Amyloid Beta Peptide, and a Composition for Suppression of PGE2, TNF-alpha, or IL-1beta Production Induced by Amyloid Beta Peptide | 2021-09-02 |
20210267915 | USE OF MITOXANTRONE LIPOSOME FOR TREATING NON-HODGKIN'S LYMPHOMA | 2021-09-02 |
20210267916 | Formulation for Inhibiting Formation of 5-HT2B Agonists and Methods of Using Same | 2021-09-02 |
20210267917 | FOOD SUPPLEMENT AND COMPOSITION COMPRISING CHOLINE BUTYRATE SALT AND/OR BUTYRYLCHOLINE | 2021-09-02 |
20210267918 | PHARMACEUTICAL COMBINATION FOR USE IN AGE-RELATED AND/OR DEGENERATIVE DISEASES | 2021-09-02 |
20210267919 | STABILIZED COATED BUTYRATE FOR COLON RELEASE | 2021-09-02 |
20210267920 | Method of and Improved Composition for Treating Triterpene-Responsive Conditions, Diseases or Disorders | 2021-09-02 |
20210267921 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLODYNIA CAUSED BY ANTICANCER AGENTS | 2021-09-02 |
20210267922 | THERAPEUTIC METHODS AND COMPOSITIONS FOR TREATING PANCREATIC CANCER USING 6,8-BIS-BENZYLTHIO-OCTANOIC ACID | 2021-09-02 |
20210267923 | SUCCINIC ACID AND DERIVATIVES FOR THE TREATMENT OF HAEMOTOLOGICAL DISORDERS | 2021-09-02 |
20210267924 | Effects of Heparin on Topical Use of Plasters Containing a Non-Steroidal Anti-Inflammatory Drug | 2021-09-02 |
20210267925 | Effects of Heparin on Topical Use of Plasters Containing a Non-Steroidal Anti-Inflammatory Drug | 2021-09-02 |
20210267926 | EFLORNITHINE AND SULINDAC, FIXED DOSE COMBINATION FORMULATION | 2021-09-02 |
20210267927 | SELF-EMULSIFYING COMPOSITION OF OMEGA3 FATTY ACID | 2021-09-02 |
20210267928 | MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS | 2021-09-02 |
20210267929 | COMPOSITIONS AND METHODS FOR TREATMENT OF ORAL ULCERATION AND ORAL MUCOSITIS | 2021-09-02 |
20210267930 | MODIFIED ANTIBODY-ALBUMIN NANOPARTICLE COMPLEXES FOR CANCER TREATMENT | 2021-09-02 |
20210267931 | USE OF DRONEDARONE FOR THE PREPARATION OF A MEDICAMENT FOR USE IN THE PREVENTION OF CARDIOVASCULAR HOSPITALIZATION OR OF MORTALITY | 2021-09-02 |
20210267932 | COMPOUNDS, COMPOSITIONS, METHODS OF USING, AND METHODS FOR PREPARING COMPOUNDS | 2021-09-02 |
20210267933 | ORAL CANNABINOID TABLET | 2021-09-02 |
20210267934 | CANNABINOID ORAL DISPERSIBLE FILM STRIP | 2021-09-02 |
20210267935 | CANNABIS PRODUCT | 2021-09-02 |
20210267936 | COMBINATION THERAPIES | 2021-09-02 |
20210267937 | METHODS FOR THE TREATMENT OF INFLAMMATION | 2021-09-02 |
20210267938 | MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF | 2021-09-02 |
20210267939 | COMPOSITIONS AND METHODS FOR TREATING NAFLD/NASH AND RELATED DISEASE PHENOTYPES | 2021-09-02 |
20210267940 | USE OF (1R,5S)-(+)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE IN THE TREATMENT OF CONDITIONS AFFECTED BY MONOAMINE NEUROTRANSMITTERS | 2021-09-02 |
20210267941 | METHOD FOR PREPARING CHLOROPHYLL-CONTAINING EXTRACT | 2021-09-02 |
20210267942 | MELATONIN FOR PREVENTING AND TREATING RADIATION VAGINITIS AND PROCTITIS | 2021-09-02 |
20210267943 | COMPOSITIONS AND METHODS FOR TREATING TISSUE INJURY | 2021-09-02 |
20210267944 | METHODS FOR TREATING AGITATION USING DEXMEDETOMIDINE HYDROCHLORIDE | 2021-09-02 |
20210267945 | DRUG COMPOSITIONS | 2021-09-02 |
20210267946 | COMBINATION TREATING PROSTATE CANCER, PHARMACEUTICAL COMPOSITION AND TREATMENT METHOD | 2021-09-02 |
20210267947 | TRIAZOLE BENZAMIDE DERIVATIVES AS GPR142 AGONISTS | 2021-09-02 |
20210267948 | TREATMENT OF CANCER | 2021-09-02 |
20210267949 | COMPOSITIONS AND METHODS FOR TREATING CONDITIONS RELATED TO ELEVATED LEVELS OF EOSINOPHILS AND/OR BASOPHILS | 2021-09-02 |
20210267950 | METHODS OF TREATING TUBEROUS SCLEROSIS COMPLEX WITH CANNABIDIOL AND EVEROLIMUS | 2021-09-02 |
20210267951 | COMBINATION THERAPY FOR PULMONARY HYPERTENSION | 2021-09-02 |
20210267952 | TREATMENT OF HUMAN CORONAVIRUS INFECTIONS USING ALPHA-GLUCOSIDASE GLYCOPROTEIN PROCESSING INHIBITORS | 2021-09-02 |
20210267953 | SUBSTITUTED OXAZOLIDINONES FOR THE TREATMENT OF MAMMALIAN INFECTIONS | 2021-09-02 |
20210267954 | GRANULES CONTAINING DIAMINE DERIVATIVE | 2021-09-02 |
20210267955 | LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF PIRFENIDONE OR SALT THEREOF | 2021-09-02 |
20210267956 | DOSING REGIMENS FOR 2-HYDROXY-6-((2-(1-ISOPROPYL-1H-PYRAZOL-5-YL)PYRIDIN-3-YL)METHOXY)BENZALD- EHYDE | 2021-09-02 |
20210267957 | METHYLPHENIDATE COMPOSITIONS FOR TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER | 2021-09-02 |
20210267958 | NONSELECTIVE METABOTROPIC GLUTAMATE RECEPTOR ACTIVATORS FOR TREATMENT OF ANOREXIA NERVOSA AND BINGE EATING DISORDER | 2021-09-02 |
20210267959 | METHODS OF TREATING RENAL DISEASE | 2021-09-02 |
20210267960 | METHODS OF TREATMENT OF INFLAMMATORY CYTOKINE-RELATED ARTHRITIC DISORDERS | 2021-09-02 |
20210267961 | METHOD OF TREATING LAMINOPATHIES | 2021-09-02 |
20210267962 | Regimens of Tafenoquine for Prevention of Malaria in Malaria-Naive Subjects | 2021-09-02 |
20210267963 | METHODS FOR THE TREATMENT AND PREVENTION OF LUNG INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA, FUNGUS, OR VIRUS BY ADMINISTRATION OF TAFENOQUINE | 2021-09-02 |
20210267964 | NLRP3 MODULATORS | 2021-09-02 |
20210267965 | COMPOUNDS AND METHODS FOR SYNERGISTIC ACTIVATION OF M CHANNELS | 2021-09-02 |
20210267966 | Method of Inducing Dendritic and Synaptic Genesis in Neurodegenerative Chronic Diseases | 2021-09-02 |
20210267967 | BUPROPION AS A MODULATOR OF DRUG ACTIVITY | 2021-09-02 |
20210267968 | Compositions And Methods For Reducing Food Cravings | 2021-09-02 |
20210267969 | Pharmaceutical Composition Comprising Aldehyde Inhibitor and Anticancer Agent for Treatment of Brain Cancer | 2021-09-02 |
20210267970 | METHODS OF TREATING DISEASE WITH LEVOKETOCONAZOLE | 2021-09-02 |
20210267971 | 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES | 2021-09-02 |
20210267972 | ADMINISTRATION OF SUMO-ACTIVATING ENZYME INHIBITOR AND ANTI-CD20 ANTIBODIES | 2021-09-02 |
20210267973 | COMBINATION OF A TYPE II PROTEIN ARGININE METHYLTRANSFERASE INHIBITOR AND AN ICOS BINDING PROTEIN TO TREAT CANCER | 2021-09-02 |
20210267974 | Azetidine Derivatives | 2021-09-02 |
20210267975 | AMORPHOUS NILOTINIB MICROPARTICLES AND USES THEREOF | 2021-09-02 |
20210267976 | PHARMACEUTICAL COMPOSITION FOR TOPICAL WOUND TREATMENT | 2021-09-02 |
20210267977 | CONTROLLING EFFECTS AFTER 5HT2A AGONISTS ADMINISTRATION | 2021-09-02 |
20210267978 | NANOPARTICLE FORMULATIONS OF IKE AND METHODS OF USE THEREOF | 2021-09-02 |
20210267979 | THERAPEUTIC AGENT FOR TREATING DIFFUSE GASTRIC CANCER | 2021-09-02 |
20210267980 | CANCER TREATMENT METHODS BASED ON TP53 MUTATION STATUS AND HYPERMUTATION STATUS | 2021-09-02 |
20210267981 | COMPOUNDS FOR THE TREATMENT OF HIV INFECTION AND OTHER DISEASES CAUSED BY RNA VIRUSES | 2021-09-02 |
20210267982 | FOLATE PREPARATIONS | 2021-09-02 |
20210267983 | COMBINATIONS OF PPAR AGONISTS AND P38 KINASE INHIBITORS FOR PREVENTING OR TREATING FIBROTIC DISEASES | 2021-09-02 |
20210267984 | APPLICATION OF ALLOPURINOL IN PREPARATION OF DRUG FOR TREATING CANCER WITH HIGH EXPRESSION OF PAICS GENE | 2021-09-02 |
20210267985 | COMPOSITIONS AND METHODS FOR INDUCING ENHANCED BRAIN FUNCTION | 2021-09-02 |
20210267986 | THERAPEUTIC REGIMENS FOR TREATMENT OF CANCER USING ERIBULIN AND SELECTIVE CDK4/6 INHIBITOR COMBINATIONS | 2021-09-02 |
20210267987 | NON-CATALYTIC SUBSTRATE-SELECTIVE, P38ALPHA-SPECIFIC MAPK INHIBITORS WITH ENDOTHELIAL-STABILIZING AND ANTI-INFLAMMATORY ACTIVITY, AND METHODS OF USE THEREOF | 2021-09-02 |
20210267988 | PHARMACEUTICAL AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPH- OLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREA | 2021-09-02 |
20210267989 | Novel Compounds for the Treatment, Alleviation or Prevention of Disorders Associated with Tau Aggregates | 2021-09-02 |
20210267990 | METHOD FOR TREATING CANCER | 2021-09-02 |
20210267991 | METHODS FOR TREATING PTEN DEFICIENT EPITHELIAL CANCERS USING A COMBINATION OF ANTI-PI3KBETA AND ANTI-IMMUNE CHECKPOINT AGENTS | 2021-09-02 |
20210267992 | 5-ACETAMIDOMETHYL-OXAZOLIDINONE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER | 2021-09-02 |
20210267993 | THIADIAZINE DERIVATIVES | 2021-09-02 |
20210267994 | 2-PHENYLIMIDAZO[4,5-B]PYRIDIN-7-AMINE DERIVATES USEFUL AS INHIBITORS OF MAMMALIAN TYROSINE KINASE ROR1 ACTIVITY | 2021-09-02 |
20210267995 | ANTI-RETROVIRAL THERAPIES AND REVERSE TRANSCRIPTASE INHIBITORS FOR TREATMENT OF ALZHEIMER'S DISEASE | 2021-09-02 |
20210267996 | Compounds for inhibition of inflammation | 2021-09-02 |
20210267997 | Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain Cancer | 2021-09-02 |
20210267998 | METHODS AND COMPOSITIONS FOR TREATMENT OF PERIPHERAL NEUROPATHIES | 2021-09-02 |
20210267999 | USE OF DOPAMINE AND SEROTONIN RECEPTOR ANTAGONISTS FOR TREATMENT IN A SUBJECT WITH RETINAL DEGENERATION | 2021-09-02 |
20210268000 | NEFOPAM DOSAGE FORMS AND METHODS OF TREATMENT | 2021-09-02 |
20210268001 | USE OF MIOTIC CHOLINERGIC SUBSTANCES AND F2a PROSTAGLANDIN ANALOGUES FOR PREVENTION AND TREATMENT OF MYOPIA | 2021-09-02 |
20210268002 | ANDROGEN COMPOSITION FOR TREATING AN OPTHALMIC CONDITION | 2021-09-02 |
20210268003 | ANIONIC DRUG-CONTAINING OPHTHALMIC DEVICE | 2021-09-02 |
20210268004 | COMPOSITION CONTAINING BECLOMETHASONE FOR THE PREVENTION AND THE TREATMENT OF BACTERIAL PROSTATITIS AND VAGINITIS | 2021-09-02 |
20210268005 | COMPOSITION COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN IMPROVING, ENHANCING, PROMOTING OR MODULATING A GABAERGIC FUNCTION IN THE CENTRAL NERVOUS SYSTEM | 2021-09-02 |
20210268006 | USE OF MANNURONIC DIACID COMPOSITION IN TREATMENT OF VASCULAR DEMENTIA | 2021-09-02 |
20210268007 | TREATMENT OF TRIPLE NEGATIVE BREAST CANCER | 2021-09-02 |
20210268008 | COMPOSITIONS AND METHODS FOR TREATMENT OF MITOCHONDRIAL RESPIRATORY CHAIN DYSFUNCTION AND OTHER MITOCHONDRIAL DISORDERS | 2021-09-02 |
20210268009 | Composition For Preventing Hair Loss Or Promoting Hair Regrowth | 2021-09-02 |
20210268010 | PHARMACEUTICAL COMPOSITION AND METHOD FOR NEOANGIOGENESIS/REVASCULARIZATION USEFUL IN TREATING ISCHEMIC HEART DISEASE | 2021-09-02 |
20210268011 | AMPK ACTIVATING AGENT | 2021-09-02 |